BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 28398024)

  • 1. Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in breast cancer patients.
    Conte B; Del Mastro L
    Minerva Ginecol; 2017 Aug; 69(4):350-356. PubMed ID: 28398024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporary ovarian suppression during chemotherapy to preserve ovarian function and fertility in breast cancer patients: A GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology.
    Lambertini M; Cinquini M; Moschetti I; Peccatori FA; Anserini P; Valenzano Menada M; Tomirotti M; Del Mastro L
    Eur J Cancer; 2017 Jan; 71():25-33. PubMed ID: 27940355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in cancer women: systematic review and meta-analysis of randomized trials.
    Del Mastro L; Ceppi M; Poggio F; Bighin C; Peccatori F; Demeestere I; Levaggi A; Giraudi S; Lambertini M; D'Alonzo A; Canavese G; Pronzato P; Bruzzi P
    Cancer Treat Rev; 2014 Jun; 40(5):675-83. PubMed ID: 24360817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preserving fertility when choosing chemotherapy regimens - the role of gonadotropin-releasing hormone agonists.
    Blumenfeld Z; Evron A
    Expert Opin Pharmacother; 2015 May; 16(7):1009-20. PubMed ID: 25826240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: a meta-analysis of randomized studies.
    Lambertini M; Ceppi M; Poggio F; Peccatori FA; Azim HA; Ugolini D; Pronzato P; Loibl S; Moore HC; Partridge AH; Bruzzi P; Del Mastro L
    Ann Oncol; 2015 Dec; 26(12):2408-19. PubMed ID: 26347105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preservation of gonadal function in women undergoing chemotherapy: a review of the potential role for gonadotropin-releasing hormone agonists.
    Hickman LC; Valentine LN; Falcone T
    Am J Obstet Gynecol; 2016 Oct; 215(4):415-22. PubMed ID: 27422055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controversies over the use of GnRH agonists for reduction of chemotherapy-induced gonadotoxicity.
    Garrido-Oyarzún MF; Castelo-Branco C
    Climacteric; 2016 Dec; 19(6):522-525. PubMed ID: 27644002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocrine prevention of chemotherapy-induced ovarian failure.
    Blumenfeld Z; Evron A
    Curr Opin Obstet Gynecol; 2016 Aug; 28(4):223-9. PubMed ID: 27253235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risk of menopausal symptoms in premenopausal breast cancer patients and current pharmacological prevention strategies.
    Lei YY; Yeo W
    Expert Opin Drug Saf; 2021 Oct; 20(10):1163-1175. PubMed ID: 33951990
    [No Abstract]   [Full Text] [Related]  

  • 10. Protecting Ovaries During Chemotherapy Through Gonad Suppression: A Systematic Review and Meta-analysis.
    Elgindy E; Sibai H; Abdelghani A; Mostafa M
    Obstet Gynecol; 2015 Jul; 126(1):187-95. PubMed ID: 26241272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical approaches to preservation of fertility in female cancer patients.
    Del Mastro L; Giraudi S; Levaggi A; Pronzato P
    Expert Opin Pharmacother; 2011 Feb; 12(3):387-96. PubMed ID: 21254946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gonadotropin-releasing hormone agonists for ovarian protection during cancer chemotherapy: systematic review and meta-analysis.
    Senra JC; Roque M; Talim MCT; Reis FM; Tavares RLC
    Ultrasound Obstet Gynecol; 2018 Jan; 51(1):77-86. PubMed ID: 29055060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of gonadotropin-releasing hormone agonists for fertility preservation in young breast cancer patients: the benefit remains uncertain.
    Turner NH; Partridge A; Sanna G; Di Leo A; Biganzoli L
    Ann Oncol; 2013 Sep; 24(9):2224-35. PubMed ID: 23709175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies for fertility preservation in young early breast cancer patients.
    Tomasi-Cont N; Lambertini M; Hulsbosch S; Peccatori AF; Amant F
    Breast; 2014 Oct; 23(5):503-10. PubMed ID: 24934638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gonadotropin-Releasing Hormone Agonist Cotreatment During Chemotherapy May Increase Pregnancy Rate in Survivors.
    Blumenfeld Z; Zur H; Dann EJ
    Oncologist; 2015 Nov; 20(11):1283-9. PubMed ID: 26463871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian protection with gonadotropin-releasing hormone agonists during chemotherapy in cancer patients: From biological evidence to clinical application.
    Lambertini M; Horicks F; Del Mastro L; Partridge AH; Demeestere I
    Cancer Treat Rev; 2019 Jan; 72():65-77. PubMed ID: 30530271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 'An ounce of prevention is worth a pound of cure': the case for and against GnRH-agonist for fertility preservation.
    Blumenfeld Z; Katz G; Evron A
    Ann Oncol; 2014 Sep; 25(9):1719-1728. PubMed ID: 24651411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gonadotropin-Releasing Hormone Agonists During Chemotherapy for Preservation of Ovarian Function and Fertility in Premenopausal Patients With Early Breast Cancer: A Systematic Review and Meta-Analysis of Individual Patient-Level Data.
    Lambertini M; Moore HCF; Leonard RCF; Loibl S; Munster P; Bruzzone M; Boni L; Unger JM; Anderson RA; Mehta K; Minton S; Poggio F; Albain KS; Adamson DJA; Gerber B; Cripps A; Bertelli G; Seiler S; Ceppi M; Partridge AH; Del Mastro L
    J Clin Oncol; 2018 Jul; 36(19):1981-1990. PubMed ID: 29718793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective study to optimize care and improve knowledge on ovarian function and/or fertility preservation in young breast cancer patients: Results of the pilot phase of the PREgnancy and FERtility (PREFER) study.
    Lambertini M; Fontana V; Massarotti C; Poggio F; Dellepiane C; Iacono G; Abate A; Miglietta L; Ferreccio C; Pescio MC; Conte B; Blondeaux E; Bighin C; D'Alonzo A; Vaglica M; Zanardi E; Boccardo F; Ballestrero A; Anserini P; Del Mastro L
    Breast; 2018 Oct; 41():51-56. PubMed ID: 30007268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can ovarian suppression with gonadotropin-releasing hormone analogs (GnRHa) preserve fertility in cancer patients?
    Rodriguez-Wallberg K; Turan V; Munster P; Oktay K
    Ann Oncol; 2016 Feb; 27(2):357. PubMed ID: 26609009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.